First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure

被引:61
作者
Galeva, S. [1 ,2 ]
Gil, M. M. [1 ,3 ,4 ]
Konstantinidou, L. [1 ]
Akolekar, R. [2 ,5 ]
Nicolaides, K. H. [1 ]
机构
[1] Kings Coll Hosp London, Fetal Med Res Inst, 16-20 Windsor Walk,Denmark Hill, London SE5 8BB, England
[2] Medway Maritime Hosp, Dept Fetal Med, Gillingham, Kent, England
[3] Univ Francisco Vitoria, Sch Hlth Sci, Madrid, Spain
[4] Hosp Univ Torrejon, Obstet & Gynecol Dept, Madrid, Spain
[5] Canterbury Christ Church Univ, Inst Med Sci, Chatham, Kent, England
关键词
cell-free DNA; fetal fraction; first-trimester screening; non-invasive prenatal testing; trisomy; 13; 18; 21; twin pregnancy; CELL-FREE DNA; WEEKS GESTATION RELATION; 1ST TRIMESTER; DOWN-SYNDROME; FETAL; IMPLEMENTATION; ANEUPLOIDIES; IMPACT;
D O I
10.1002/uog.20290
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective To examine factors affecting the rate of failure to obtain a result from cell-free DNA (cfDNA) testing of maternal blood for fetal trisomies 21, 18 and 13 in singleton and twin pregnancies in the first trimester. Methods This was a prospective study of 23 495 singleton and 928 twin pregnancies undergoing screening for fetal trisomy by targeted cfDNA testing at 10+0 to 14+1 weeks' gestation. Multivariate logistic regression analysis was used to determine significant predictors of failure to obtain a result after first sampling. Results There was no result from cfDNA testing after first sampling in 3.4% (798/23 495) of singletons, 11.3% (91/806) of dichorionic twins and 4.9% (6/122) of monochorionic twins. Multivariate logistic regression analysis demonstrated that the risk of test failure, first, increased with increasing maternal age (odds ratio (OR), 1.02; 95% CI, 1.01-1.04) and weight (OR, 1.05; 95% CI, 1.04-1.05), decreasing gestational age (OR, 0.85; 95% CI, 0.79-0.91), serum pregnancy-associated plasma protein-A (PAPP-A) multiples of the median (MoM) (OR, 0.56; 95% CI, 0.49-0.65) and free beta-human chorionic gonadotropin (beta-hCG) MoM (OR, 0.67; 95% CI, 0.60-0.74), second, was higher in women of black (OR, 1.72; 95% CI, 1.33-2.20) and South Asian (OR, 1.99; 95% CI, 1.56-2.52) than those of white racial origin, in dichorionic twin than in singleton pregnancy (OR, 1.75; 95% CI, 1.34-2.26) and in pregnancies conceived by in-vitro fertilization than in those conceived naturally (OR, 3.82; 95% CI, 3.19-4.55) and, third, was lower in parous than in nulliparous women (OR, 0.63; 95% CI, 0.55-0.74). Conclusions Maternal age, weight, racial origin and parity, gestational age, dichorionicity, method of conception and serum levels of free beta-hCG and PAPP-A are independent predictors of cfDNA test failure. The risk of test failure is higher in dichorionic twin than in singleton pregnancies, mainly because a higher proportion of twins are conceived by in-vitro fertilization and more of the women are nulliparous. Copyright (c) 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
收藏
页码:804 / 809
页数:6
相关论文
共 31 条
[1]   Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome [J].
Amor, D. J. ;
Xu, J. X. ;
Halliday, J. L. ;
Francis, I. ;
Healy, D. L. ;
Breheny, S. ;
Baker, H. W. G. ;
Jaques, A. M. .
HUMAN REPRODUCTION, 2009, 24 (06) :1330-1338
[2]  
[Anonymous], 2017, R LANG ENV STAT COMP
[3]   Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics [J].
Ashoor, G. ;
Syngelaki, A. ;
Poon, L. C. Y. ;
Rezende, J. C. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 41 (01) :26-32
[4]   Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method [J].
Ashoor, G. ;
Syngelaki, A. ;
Wang, E. ;
Struble, C. ;
Oliphant, A. ;
Song, K. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 41 (01) :21-25
[5]   Fetal Fraction in Maternal Plasma Cell-Free DNA at 11-13 Weeks' Gestation: Effect of Maternal and Fetal Factors [J].
Ashoor, Ghalia ;
Poon, Leona ;
Syngelaki, Argyro ;
Mosimann, Beatrice ;
Nicolaides, Kypros H. .
FETAL DIAGNOSIS AND THERAPY, 2012, 31 (04) :237-243
[6]   Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies [J].
Bevilacqua, E. ;
Gil, M. M. ;
Nicolaides, K. H. ;
Ordonez, E. ;
Cirigliano, V. ;
Dierickx, H. ;
Willems, P. J. ;
Jani, J. C. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2015, 45 (01) :61-66
[7]   Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study [J].
Chan, N. ;
Smet, M-E ;
Sandow, R. ;
Costa, F. da Silva ;
McLennan, A. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 (07) :848-855
[8]   Contribution of Method of Conception on Pregnancy Outcome after the 11-13 Weeks Scan [J].
Chaveeva, Petya ;
Carbone, Ilma F. ;
Syngelaki, Argyro ;
Akolekar, Ranjit ;
Nicolaides, Kypros H. .
FETAL DIAGNOSIS AND THERAPY, 2011, 30 (01) :9-22
[9]   Validation of Correction Factors for Serum Markers for First-Trimester Down Syndrome Screening in Singleton Pregnancies Conceived with Assisted Reproduction [J].
Engels, Melanie A. J. ;
Pajkrt, Eva ;
Groot, Dominique T. ;
Schats, Roel ;
Twisk, Jos W. R. ;
van Vugt, John M. G. .
FETAL DIAGNOSIS AND THERAPY, 2013, 34 (04) :217-224
[10]   Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test [J].
Galeva, S. ;
Konstantinidou, L. ;
Gil, M. M. ;
Akolekar, R. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2019, 53 (02) :208-213